Potential effects of Thymus vulgaris L. on the gene expression of inhibin A, inhibin B, and Aromatase (CYP19A1) in a letrozole-induced PCOS rat model
Authors:
- Heba SabraHSHeba Sabra
- Noha El-ZeinyNENoha El-Zeiny
- Sara AtwaSASara Atwa
- Mona RadyMRMona Rady
- Sahar Abdel MaksoudSMSahar Abdel Maksoud
- Heba HandoussaHHHeba Handoussa
Open Access
- 15 July 2026
- journal article
- Published by Springer Nature in Future Journal of Pharmaceutical Sciences
- Vol. 12 (1)
Abstract
Background: Polycystic ovary syndrome (PCOS) is one of the main causes of infertility in women of reproductive age. Hyperandrogenism and anovulation are common mostly in women with PCOS. Metformin was the first insulin sensitizer to be used in PCOS management to improve ovulation and reduce androgen levels. The currently available medication depends mainly on hormonal therapy such as combined oral contraceptives, anti-androgens, and ovulation-inducing agents, which help regulate menstrual cycles and reduce hyperandrogenism but potentially leading to some complications. However, alternative treatments with special insights into medicinal plants have become reliable and safer approaches with better outcomes. The present study aimed to explore the therapeutic potential of Thymus vulgaris leaves ( Thymus v. ) in a letrozole-induced PCOS rat model compared with that of metformin. Letrozole-induced PCOS rats were treated with total Thymus v. extract in a dose-dependent manner (50, 75 and 100 mg/kg) and with metformin orally for 14 consecutive days. HPLC–PDA-ESI–MS/MS was used for the phytochemical characterization of the bioactive extract. Results: Treatment with the different doses resulted in a significant decrement of the gene expression levels of inhibin A, inhibin B and CYP19A1, which was further confirmed by immunohistochemistry. Additionally, Thymus v. restored hormonal equilibrium by modulating steroidogenic enzymes (estrogen, progesterone and testosterone), specifically by tuning gonadotropin levels and correcting the LH-to-FSH. The restoration of the normal morphological architecture of ovaries and follicular growth was supported by histopathological examination. Conclusion: This study provides insights into the mechanistic impact of Thymus v . as a multifaceted therapeutic nutraceutical in hormonal and molecular imbalances in PCOS.Keywords
Funding Information
- Constructor University Bremen gGmbH
This publication has 57 references indexed in Scilit:
- Modulatory impact of wheat metabolome on Wnt/β-catenin signaling pathway in an obesity-induced rat modelFood Bioscience, 2025
- Roxadustat alleviates metabolic traits in letrozole-induced PCOS miceBiochemical Pharmacology, 2024
- Inhibin subunit beta B (INHBB): an emerging role in tumor progressionJournal of Physiology and Biochemistry, 2024
- Evaluating flavonoids as potential aromatase inhibitors for breast cancer treatment: In vitro studies and in silico predictionsChemico-Biological Interactions, 2024
- A review on critical appraisal and pathogenesis of polycystic ovarian syndromeEndocrine and Metabolic Science, 2024
- Diacerein ameliorates letrozole-induced polycystic ovarian syndrome in ratsBiomedicine & Pharmacotherapy, 2022
- Activin and inhibin signaling: From regulation of physiology to involvement in the pathology of the female reproductive systemCytokine, 2020
- Phenolic and carotenoid profiles of papaya fruit (Carica papaya L.) and their contents under low temperature storageJournal of the Science of Food and Agriculture, 2010
- Cytochrome P450 aromatase gene (CYP19) expression in gastric cancerGastric Cancer, 2008
- Uterine myomas, dyspareunia, and sexual functionFertility and Sterility, 2006